• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Donate Now
  • Sign up for CMA’s weekly newsletter!

Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

  • Eligibility/Enrollment
  • Coverage/Appeals
    • Medicare Costs
    • Self Help Materials – Toolkits & More
  • Topics
    • Basic Introduction to Medicare
    • Medicare Costs
    • Home Health Care
    • Improvement Standard and Jimmo News
    • Nursing Home / Skilled Nursing Facility Care
    • Outpatient Observation Status
    • Part B
    • Part D / Prescription Drug Benefits
    • Medicare for People Under 65
    • Medicare “Reform”
    • All Other Topics
    • Resources
      • Infographics
  • Publications
    • CMA Alerts
    • Fact Sheets & Issue Briefs
    • Infographics
    • The Medicare Handbook
    • SNF Enforcement Newsletter
    • Elder Justice Newsletter
    • Medicare Facts & Fiction
    • Articles by Topic
  • Litigation
    • Litigation News
    • Cases
    • Litigation Archive
    • Amicus Curiae Activities
  • Newsroom
    • Press Releases
    • Editorials & Letters to the Editor
    • CMA Comments, Responses, and Letters
    • CMA in the News
  • About Us
    • National Voices of Medicare Summit
    • Mission Statement
    • CMA FAQs
    • CMA Annual Impact Report
    • Personnel & Boards
    • The Center for Medicare Advocacy Founder’s Circle
    • Connecticut Dually Eligible Appeals Project
    • Community Outreach and Education Project (COEP)
    • National Medicare Advocates Alliance
    • CMA Webinars
    • Products & Services
    • Testimonials
    • Career, Fellowship & Internship Opportunities
    • Contact Us
  • Support Our Work
    • Donate Now
    • Build a Legacy with CMA
    • Join the Center for Medicare Advocacy Founder’s Circle
    • Take Action
    • Share Your Health Care Story
    • Tell Congress to Protect Our Care
    • Listen to Medicare & Health Care Stories
    • Sign up for CMA’s weekly newsletter!

antipsychotics

HHS Inspector General: Too Many Nursing Home Residents Still Inappropriately Receive Psychotropic Medications

December 8, 2022

The HHS Office of Inspector General (OIG) reports that, from 2011 through 2019, about 80% of long-stay nursing home residents were prescribed a psychotropic drug (defined as “any drug that affects brain activities associated with mental processes and … [Read more...] about HHS Inspector General: Too Many Nursing Home Residents Still Inappropriately Receive Psychotropic Medications

Filed Under: Article Tagged With: antipsychotics, Skilled Nursing Facility, Weekly Alert

HHS Inspector General Finds CMS Data Understates Antipsychotic Drug Use in Nursing Homes

May 13, 2021

A serious and longstanding quality of care problem in nursing homes is the inappropriate use of antipsychotic drugs with residents who have dementia.  A decade ago, the HHS Office of Inspector General (OIG) reported that 83% of claims for … [Read more...] about HHS Inspector General Finds CMS Data Understates Antipsychotic Drug Use in Nursing Homes

Filed Under: Article Tagged With: antipsychotics, Skilled Nursing Facility, Weekly Alert

Drug Company Sued Over Kickbacks for Off-Label Marketing of Psychotropic Drug for Nursing Home Residents to Pay Over $115 Million

October 17, 2019

BackgroundWhen the Centers for Medicare & Medicaid Services (CMS) launched a national campaign to reduce the off-label prescribing of antipsychotic drugs for nursing home residents in 2012, Avanir Pharmaceuticals directed its sales force to … [Read more...] about Drug Company Sued Over Kickbacks for Off-Label Marketing of Psychotropic Drug for Nursing Home Residents to Pay Over $115 Million

Filed Under: Article Tagged With: antipsychotics, Skilled Nursing Facility, Weekly Alert

Stop Drugging Nursing Home Residents Without their Written Consent

August 29, 2019

Background. Nursing homes administer antipsychotic drugs to approximately 20 percent of residents nationwide. Sadly, and too often, nursing homes use these drugs as a way of chemically restraining residents exhibiting the behavioral symptoms of … [Read more...] about Stop Drugging Nursing Home Residents Without their Written Consent

Filed Under: Article Tagged With: antipsychotics, Skilled Nursing Facility, Weekly Alert

Study Finds Link Between Registered Nurse Hours and Antipsychotic Drug Use

September 20, 2018

Human Rights Watch (HRW) published a devastating report in February 2018, which found that over 179,000 nursing home residents were being administered off-label antipsychotic drugs every week.[1] Antipsychotic drugs are indicated to treat specific … [Read more...] about Study Finds Link Between Registered Nurse Hours and Antipsychotic Drug Use

Filed Under: Article Tagged With: antipsychotics, SNF Staffing, Weekly Alert

Did CMS’s Partnership to Improve Dementia Care Reduce the Inappropriate Prescribing of Antipsychotic Drugs for Nursing Home Residents as Much as CMS Claims? Two Recent Studies Say No

June 28, 2018

The Centers for Medicare & Medicaid Services (CMS) has ended its campaign to reduce the inappropriate use of antipsychotic drugs for long-stay residents in nursing facilities (formally called the National Partnership to Improve Dementia Care in … [Read more...] about Did CMS’s Partnership to Improve Dementia Care Reduce the Inappropriate Prescribing of Antipsychotic Drugs for Nursing Home Residents as Much as CMS Claims? Two Recent Studies Say No

Filed Under: Article Tagged With: antipsychotics, Skilled Nursing Facility, Weekly Alert

Elder Justice Alert: New York Times Publishes Article on Drug Use Among Older Adults

March 29, 2018

Revelations have shed light on an opioid crises in the United States that remained largely hidden until recently. These drugs have affected the lives of children and adults nationwide. Unfortunately, the inappropriate use of medication – … [Read more...] about Elder Justice Alert: New York Times Publishes Article on Drug Use Among Older Adults

Filed Under: Article Tagged With: antipsychotics, elder justice, Skilled Nursing Facility, Weekly Alert

Elder Justice Alert: Human Rights Watch Publishes In-Depth Report on Antipsychotic Drug Use in U.S. Nursing Homes

February 7, 2018

On February 5, 2018, Human Rights Watch published an in-depth report on antipsychotic drug use in U.S. nursing homes. The Report, entitled “‘They Want Docile’: How Nursing Homes in the United States Overmedicate People with … [Read more...] about Elder Justice Alert: Human Rights Watch Publishes In-Depth Report on Antipsychotic Drug Use in U.S. Nursing Homes

Filed Under: Article Tagged With: antipsychotics, Skilled Nursing Facility, Weekly Alert

CMA Alert, October 18, 2017 – Nursing Home Rights Roundup; ACA Stabilization; More

October 18, 2017

This Week in ACA Sabotage Bipartisan Agreement on ACA Stabilization Package Nursing Home Rights Roundup CMS Signals End of Campaign to Reduce Unnecessary Use of Antipsychotic Drugs In Nursing Homes; Claim of Success is Grossly … [Read more...] about CMA Alert, October 18, 2017 – Nursing Home Rights Roundup; ACA Stabilization; More

Filed Under: Article Tagged With: ACA, antipsychotics, Skilled Nursing Facility, The Fight, Weekly Alert

Elder Abuse in Nursing Facilities: The Over-Administration of Antipsychotic Drugs to Nursing Home Residents

June 15, 2016

The Administration on Aging defines a subcategory of elder abuse – “physical abuse” – as “inflicting physical pain or injury on a senior, e.g. slapping, bruising, or restraining by physical or chemical … [Read more...] about Elder Abuse in Nursing Facilities: The Over-Administration of Antipsychotic Drugs to Nursing Home Residents

Filed Under: Article Tagged With: antipsychotics, Skilled Nursing Facility, Weekly Alert

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

Easy Access to Understanding Medicare

The Center for Medicare Advocacy produces a range of informative materials on Medicare-related topics.
Sign Up for CMA's Free Newsletter
Register for CMA's Free Webinars

  • Medicare Basics
  • Medicare Reform
  • CMA Alerts
  • Fact Sheets & Issue Briefs
  • CMA Webinars
  • Connecticut Info & Projects
  • Health Care Stories
  • Se habla Español

Jimmo v. Sebelius

Medicare covers skilled care to maintain or slow decline as well as to improve.

Improvement Isn’t Required. It’s the law!

Read more.

National Voices of Medicare Summit

With the many threats currently facing the Medicare program, now is the time to come together as allies and explore ways to advocate for comprehensive Medicare coverage, health equity, and quality health care. Drawing inspiration from real-life experiences and stories of beneficiaries and caregivers, we hope to share impactful discussions with you.

Learn more.

Center for Medicare Advocacy Follow 10,541 5,336

A national nonpartisan, nonprofit law organization working to advance access to comprehensive #Medicare coverage and quality #healthcare.

CMAorg
CMAorg avatar Center for Medicare Advocacy @CMAorg ·
13 Mar 2032514309784220116

AI to fight Medicare fraud?

CMS is proposing new “CRUSH” rules using analytics and AI to flag suspicious claims.

But David Lipschutz of the Center for Medicare Advocacy warns medically necessary care could be caught in the crossfire.

More audits. More scrutiny. What does that

Reply on Twitter 2032514309784220116 Retweet on Twitter 2032514309784220116 1 Like on Twitter 2032514309784220116 1 X 2032514309784220116
Retweet on Twitter Center for Medicare Advocacy Retweeted
matthewherper avatar Matthew Herper @matthewherper ·
13 Mar 2032465053262196859

You can buy tickets to attend the STAT Breakthrough Summit East at this link:

Image for twitter card

STAT Summit East

agenda is now live  · agenda is now live  · agenda is now live  · agenda is now live  · agenda is now live  · agenda is now

www.statnews.com

Reply on Twitter 2032465053262196859 Retweet on Twitter 2032465053262196859 1 Like on Twitter 2032465053262196859 2 X 2032465053262196859
CMAorg avatar Center for Medicare Advocacy @CMAorg ·
12 Mar 2032166580935647730

Some retirees are being automatically enrolled into Medicare Advantage plans by former employers or unions — even if they didn’t actively choose the plan.

Our new issue brief examines how this happens and why it raises concerns about beneficiary choice.

Stay informed on

Reply on Twitter 2032166580935647730 Retweet on Twitter 2032166580935647730 1 Like on Twitter 2032166580935647730 1 X 2032166580935647730
Retweet on Twitter Center for Medicare Advocacy Retweeted
alsadvocacy avatar ALS Advocacy @alsadvocacy ·
11 Mar 2031652436721492445

How do we get access to the "leading ALS scientific conference?"

Image for twitter card

PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference

/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focu...

www.prnewswire.com

Reply on Twitter 2031652436721492445 Retweet on Twitter 2031652436721492445 1 Like on Twitter 2031652436721492445 2 X 2031652436721492445
Load More

Footer

Stay Connected:

  • Contact Us
  • Sitemap
  • Products & Services
  • Copyright/Privacy

© 2026 · Center for Medicare Advocacy